KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,484,770 | -22.1% | 38,351 | -0.0% | 0.06% | -15.6% |
| Q2 2023 | $8,320,317 | +19.4% | 38,369 | +0.0% | 0.08% | +11.6% |
| Q1 2023 | $6,966,075 | -7.2% | 38,351 | +0.4% | 0.07% | -11.5% |
| Q4 2022 | $7,508,462 | -12.6% | 38,211 | 0.0% | 0.08% | -20.4% |
| Q3 2022 | $8,595,000 | +77.8% | 38,211 | 0.0% | 0.10% | +88.5% |
| Q2 2022 | $4,834,000 | -0.2% | 38,211 | 0.0% | 0.05% | +15.6% |
| Q1 2022 | $4,845,000 | -3.2% | 38,211 | 0.0% | 0.04% | -2.2% |
| Q4 2021 | $5,006,000 | +7.1% | 38,211 | 0.0% | 0.05% | -2.1% |
| Q3 2021 | $4,674,000 | +7.3% | 38,211 | 0.0% | 0.05% | +6.8% |
| Q2 2021 | $4,356,000 | -5.2% | 38,211 | 0.0% | 0.04% | -20.0% |
| Q1 2021 | $4,594,000 | +18.3% | 38,211 | 0.0% | 0.06% | +7.8% |
| Q4 2020 | $3,882,000 | +31.4% | 38,211 | 0.0% | 0.05% | +18.6% |
| Q3 2020 | $2,954,000 | – | 38,211 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |